Clinical Trial Details
EORTC-20012
Back to Clinical Trials Database
BEACOPP (4 cycles escalated + 4 cycles baseline) versus ABVD (8 cycles) in stage III & IV Hodgkin's Lymphoma
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 09-Aug-2002 Date Step1 close: 08-Jan-2010 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 550 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00049595 |
| NCT number | NCT00049595 |
| EudraCT | 2004-001558-10 |
